SCHEMBL6249043

SCHEMBL6249043

CC(C)(C)c1ccc([N+](=O)[O-])cc1/C=C/C(=O)N1CCCCC1.CC(C)(C)c1ccc([N+](=O)[O-])cc1Br

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.49
MAPT P10636 4/20 0.44
MITF O75030 2/20 0.44
HTT P42858 2/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
ITGB2 P05107 2/20 0.43
ICAM1 P05362 2/20 0.43
ITGAL P20701 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
KDM4E B2RXH2 1/20 0.42
HPGD P15428 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6249048 1.00 ALDH1A1 (0.49) ALDH1A1MAPTMITFHTTSMN1; SMN2
SCHEMBL445868 0.94 ALDH1A1 (0.55) ALDH1A1MAPTMITFHTTSMN1; SMN2
SCHEMBL445867 0.94 ALDH1A1 (0.55) ALDH1A1MAPTMITFHTTSMN1; SMN2
SCHEMBL446259 0.76 ALDH1A1 (0.53) ALDH1A1MAPTSMN1; SMN2KMT2AMEN1
SCHEMBL446260 0.76 ALDH1A1 (0.53) ALDH1A1MAPTSMN1; SMN2KMT2AMEN1
SCHEMBL30279254 0.74 SMN1; SMN2 (0.50) ALDH1A1HTTSMN1; SMN2KMT2AMEN1
SCHEMBL395055 0.74 SMN1; SMN2 (0.50) ALDH1A1HTTSMN1; SMN2KMT2AMEN1
SCHEMBL6314297 0.73 HPGD (0.62) ALDH1A1MAPTMITFHTTSMN1; SMN2
SCHEMBL447370 0.70 HRH3 (0.44) ALDH1A1MAPTHTTSMN1; SMN2KMT2A
SCHEMBL447371 0.70 HRH3 (0.44) ALDH1A1MAPTHTTSMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537084-A1 SUBSTITUTED 2-ALKYLAMINE NICOTINIC AMIDE DERIVATIVES AND USE THERE OF Amgen Inc. (US) 2005-06-08 EP disclosed
WO-2004007458-A1 SUBSTITUTED 2-ALKYLAMINE NICOTINIC AMIDE DERIVATIVES AND USE THERE OF AMGEN INC. (US) 2004-01-22 WO disclosed
EP-1358184-A1 SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE Amgen Inc. (US) 2003-11-05 EP disclosed
WO-2002066470-A1 SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE AMGEN INC. (US) 2002-08-29 WO disclosed